Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AIM
AIM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AIM News
AIM ImmunoTech to Release Ebola Drug Research Video Presentation
3d ago
NASDAQ.COM
AIM ImmunoTech Announces Direct Offering of Shares
May 21 2026
NASDAQ.COM
AIM ImmunoTech Announces Registered Direct Offering of Common Stock
May 20 2026
Newsfilter
AIM ImmunoTech's Financing Plan Triggers Stock Price Plunge
May 08 2026
stocktwits
Analysis of High Growth Tech Stocks in Australia
Apr 19 2026
Yahoo Finance
AIM ImmunoTech Reports Going Concern Emphasis in Financial Statements
Apr 13 2026
Newsfilter
AIM ImmunoTech Shares Surge 80% After Japanese Patent Approval
Mar 18 2026
NASDAQ.COM
AIM ImmunoTech Secures Japanese Patent Approval
Mar 18 2026
stocktwits
AIM ImmunoTech Closes $1.8 Million Rights Offering
Mar 07 2026
Newsfilter
AIM ImmunoTech Completes Rights Offering Raising $1.8 Million
Mar 07 2026
Yahoo Finance
AIM Immunotech Inc. Enters Agreement with Thermo Fisher for Phase 3 Trial of Ampligen
Mar 02 2026
moomoo
AIM ImmunoTech Announces Rights Offering Details
Feb 12 2026
Newsfilter
AIM ImmunoTech Launches Rights Offering for $12 Million
Feb 11 2026
Newsfilter
AIM ImmunoTech to Participate in Corporate Connect Webinar
Feb 06 2026
Newsfilter
U.S. Stocks Decline in Morning Trading
Feb 05 2026
Benzinga
Healthcare Stocks Show Weak Momentum and High Valuation
Feb 03 2026
seekingalpha
Show More News
